Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with stomach cancer (specifically a type called adenocarcinoma) that has been confirmed by a tissue sample, and doctors believe it can be surgically removed.
- Your cancer is at a stage where it has grown into or through the stomach wall (but has not spread to distant parts of the body), based on scans.
- You have not had any chemotherapy, targeted therapy, or surgery to remove any part of your tumor before joining this trial.
- You are between 18 and 75 years old.
- If you are a woman who could become pregnant, you must have a negative pregnancy test within 7 days before the trial starts, and you must agree to use highly effective contraception throughout the study.
- If you are a man, you must agree to use a condom during treatment and not to father a child during the study, and your partner (if she could become pregnant) must also use effective contraception.
- You are reasonably well and able to carry out daily activities (confirm with trial site for exact fitness level required).
- Scans (CT or MRI) have confirmed that the cancer has not spread to distant areas of the body, and has not grown into surrounding organs.
- A keyhole surgical procedure (laparoscopy) has confirmed the cancer has not spread to the lining of the abdomen before chemotherapy begins.
- Your blood counts, liver function, and kidney function are within acceptable levels (confirm with trial site for exact values).
- You are willing and able to give written consent and follow the study plan, including planned surgery.
Who may not be able to join:
- You have not received any pre-surgery (neoadjuvant) chemotherapy, or you received a different chemotherapy regimen other than FLOT before joining.
- You have a known allergy or sensitivity to any of the chemotherapy drugs used in FLOT (5-FU, leucovorin, oxaliplatin, or docetaxel).
- You have any other known medical reason why you cannot take the FLOT chemotherapy drugs.
- You have significant active heart disease, a serious heart muscle condition, or severe heart failure (confirm with trial site for exact definition).
- You have a significant heart valve problem.
- Your cancer has grown into major blood vessels or nearby organs, or has spread to certain lymph nodes in the abdomen that are considered distant spread.
- You have another serious illness or an active infection.
- You have significant nerve damage in your hands or feet (confirm with trial site for exact definition).
- You have had major surgery within 28 days before joining the trial (a staging laparoscopy is an exception).
- You have significant liver scarring (cirrhosis) at a certain level of severity, or any cirrhosis combined with a history of brain complications from liver disease or fluid build-up in the abdomen.
- You are currently taking part in, or have taken part in, another interventional clinical trial within 30 days before joining or during this study.
- You are pregnant, breastfeeding, or planning to become pregnant.
- You are receiving any other cancer treatment, including radiotherapy, at the same time.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alexander Zakharenko, PhD, First Pavlov State Medical University of St. Petersburg
Phone: 9219516183
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparison of Overall survival (OS) in both arms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.